SearcharxivSearch

arXiv subjects

Mohammed Benjelloun

Publications and source records attributed to Mohammed Benjelloun.

2 recordsLinked to original sources

ZAPS: Zero-Cost Active Proxy Search for Neural Architecture Search

Neural Architecture Search (NAS) automates network design, but evaluating a single candidate requires training it to convergence, making exhaustive search intractable. Zero-cost proxies estimate architecture quality at initialization in seconds, yet a single proxy is noisy, and combining several does not straightforwardly help: proxies are strongly correlated, so naive aggregation compounds their shared errors instead of averaging them out. Existing methods exploit either proxy signals or architectural topology - never both within a single active-learning framework. We introduce ZAPS (Zero-cost Active Proxy Search), a four-stage pipeline that closes this gap. ZAPS (i) selects a compact, non-redundant proxy subset offline via ProxyFit, a greedy anti-redundancy criterion; (ii) seeds the search with a hybrid K-means strategy that balances exploitation and exploration; (iii) re-selects proxies at every iteration by a bootstrapped vote as the labeled set grows; and (iv) ranks candidates with an XGBoost ensemble trained jointly on proxy ranks and one-hot topological encodings, queried through an Upper Confidence Bound (UCB) acquisition function. On NAS-Bench-201 under a budget of B=200 evaluations, ZAPS recovers 52.3% of the true top-100 architectures on CIFAR-10 and 65.8% on CIFAR-100, ahead of every baseline we consider - Random Search, Local Search, REA, BANANAS and TPE - and, on CIFAR-10, with less than half the run-to-run standard deviation of the strongest of them. The advantage is largest where evaluations are scarce: on NAS-Bench-201 it narrows as the budget grows, whereas on the harder NAS-Bench-101, which no method comes close to saturating, it widens instead. All methods are scored by a single criterion: how much of the true top-100 lies among the architectures they actually evaluated.

cs.LG

Deep learning-based prediction of response to HER2-targeted neoadjuvant chemotherapy from pre-treatment dynamic breast MRI: A multi-institutional validation study

Predicting response to neoadjuvant therapy is a vexing challenge in breast cancer. In this study, we evaluate the ability of deep learning to predict response to HER2-targeted neo-adjuvant chemotherapy (NAC) from pre-treatment dynamic contrast-enhanced (DCE) MRI acquired prior to treatment. In a retrospective study encompassing DCE-MRI data from a total of 157 HER2+ breast cancer patients from 5 institutions, we developed and validated a deep learning approach for predicting pathological complete response (pCR) to HER2-targeted NAC prior to treatment. 100 patients who received HER2-targeted neoadjuvant chemotherapy at a single institution were used to train (n=85) and tune (n=15) a convolutional neural network (CNN) to predict pCR. A multi-input CNN leveraging both pre-contrast and late post-contrast DCE-MRI acquisitions was identified to achieve optimal response prediction within the validation set (AUC=0.93). This model was then tested on two independent testing cohorts with pre-treatment DCE-MRI data. It achieved strong performance in a 28 patient testing set from a second institution (AUC=0.85, 95% CI 0.67-1.0, p=.0008) and a 29 patient multicenter trial including data from 3 additional institutions (AUC=0.77, 95% CI 0.58-0.97, p=0.006). Deep learning-based response prediction model was found to exceed a multivariable model incorporating predictive clinical variables (AUC < .65 in testing cohorts) and a model of semi-quantitative DCE-MRI pharmacokinetic measurements (AUC < .60 in testing cohorts). The results presented in this work across multiple sites suggest that with further validation deep learning could provide an effective and reliable tool to guide targeted therapy in breast cancer, thus reducing overtreatment among HER2+ patients.

q-bio.QM